{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T05:31:35Z","timestamp":1783488695360,"version":"3.55.0"},"reference-count":30,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,4,4]],"date-time":"2019-04-04T00:00:00Z","timestamp":1554336000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"DOI":"10.3389\/fendo.2019.00192","type":"journal-article","created":{"date-parts":[[2019,4,4]],"date-time":"2019-04-04T04:36:53Z","timestamp":1554352613000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":24,"title":["Evaluation of Quality of Life in the Brazilian Graves' Disease Population: Focus on Mild and Moderate Graves' Orbitopathy Patients"],"prefix":"10.3389","volume":"10","author":[{"given":"Danilo","family":"Villagelin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo\u00e3o","family":"Romaldini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliana","family":"Andrade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Milkos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia F\u00e1tima dos Santos","family":"Teixeira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura S.","family":"Ward","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2019,4,4]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"R117","DOI":"10.1530\/EJE-15-1164","article-title":"Endocrine dilemma: management of Graves' orbitopathy","volume":"175","author":"Campi","year":"2016","journal-title":"Eur J Endocrinol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1530\/EJE-07-0666","article-title":"Consensus statement of the European Group on Graves' Orbitophaty (EUGOGO) on management of GO","volume":"158","author":"Bartalena","year":"2008","journal-title":"Eur J Endocrinol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1089\/thy.2014.0037","article-title":"What are the psychosocial outcomes of treatment for thyroid eye disease a systematic review","volume":"24","author":"Wickwar","year":"2014","journal-title":"Thyroid."},{"key":"B4","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.beem.2011.11.007","article-title":"Evaluating graves' orbitopathy","volume":"26","author":"Dolman","year":"2012","journal-title":"Best Pract Res Clin Endocrinol Metab."},{"key":"B5","doi-asserted-by":"publisher","first-page":"30046","DOI":"10.1016\/S2213-8587(16)30046-8","article-title":"Advances in treatment of active, moderate-to-severe Graves' ophtalmopathy","volume":"16","author":"Wiersinga","year":"2016","journal-title":"Lancet Diabetes Endocrinol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1089\/thy.2007.0153","article-title":"The genetic basis of thyroid autoimune","volume":"17","author":"Jacobson","year":"2007","journal-title":"Thyroid."},{"key":"B7","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1007\/s12020-016-1096-1","article-title":"CD28\/CTL-4\/ICOS haplotypes confers susceptibilty to Graves\u2018disease and modulates clinical phenotype of disease","volume":"1","author":"Adamska-Pawlak","year":"2017","journal-title":"Endocrine."},{"key":"B8","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/j.beem.2011.11.001","article-title":"Quality of life in Graves' ophthalmopathy","volume":"26","author":"Wiersinga","year":"2012","journal-title":"Best Pract Res Clin Endocrinol Metab."},{"key":"B9","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1089\/thy.1992.2.235","article-title":"Classification of eye changes of Grave's disease","volume":"2","author":"Pinchera","year":"1992","journal-title":"Thyroid."},{"key":"B10","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1016\/S0161-6420(96)30579-4","article-title":"Long-term follow up of Graves ophthalmopathy in incidence cohort","volume":"103","author":"Bartley","year":"1996","journal-title":"Ophthalmology"},{"key":"B11","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1089\/thy.1997.7.885","article-title":"Quality of life in patients with Graves' ophthalmopathy is markedly decreased: measurement by outcomes study instrument","volume":"7","author":"Gerding","year":"1997","journal-title":"Thyroid."},{"key":"B12","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1016\/S0161-6420(97)30303-0","article-title":"The impact of blurred vision on functioning and well being","volume":"104","author":"Lee","year":"1997","journal-title":"Ophtalmology."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0002-9394(14)71636-8","article-title":"Assesment of health-related quality of life after corneal transplantion","volume":"124","author":"Musch","year":"1997","journal-title":"Am J Ophthalmol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1001\/archopht.1994.01090230033017","article-title":"Improved visual function and attenuation of declines in health\u2013related quality of life after cataract extraction","volume":"112","author":"Mangione","year":"1994","journal-title":"Arch Ophthalmol."},{"key":"B15","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1136\/bjo.82.7.773","article-title":"Development of disease specific quality of life questionnaire for patients with Graves' ophthalmopathy: the GO-QOLBr","volume":"82","author":"Terwee","year":"1998","journal-title":"J Ophtalmol."},{"key":"B16","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1046\/j.1365-2265.2001.01241.x","article-title":"Interpretation and validity of changes in scores on the Graves' ophthalmopathy quality of life questionnaire (GO-QOL) after different treatments","volume":"54","author":"Terwee","year":"2001","journal-title":"Clin Endocrinol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"1920","DOI":"10.1056\/NEJMoa1012985","article-title":"Selenium and course of mild Graves' orbitophathy","volume":"364","author":"Marcocci","year":"2011","journal-title":"N Engl J Med."},{"key":"B18","doi-asserted-by":"publisher","first-page":"65","DOI":"10.3341\/kjo.2010.24.2.65","article-title":"Assessment of quality of life and depression in Korean patients withGrave's ophthalmopathy","volume":"24","author":"Lee","year":"2010","journal-title":"Korean J Ophthalmol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1590\/2359-3997000000252","article-title":"Related quality of life questionnaire specific to dysthyroid ophthalmopathy evaluated in population of patients with Graves' disease","volume":"61","author":"Delfino","year":"2017","journal-title":"Arch Endocrinol Metab"},{"key":"B20","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1046\/j.1365-2265.1997.2331047.x","article-title":"Clinical activity score as guide in the management of patients with Graves' ophthalmopathy","volume":"47","author":"Mourits","year":"1997","journal-title":"Clin Endocrinol."},{"key":"B21","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1210\/jcem-44-1-203","article-title":"Modification of the classification of the eye changes of Graves' disease: recommendations of the Ad Hoc Committee of American Thyroid Association","volume":"44","author":"Werner","year":"1977","journal-title":"J Clin Endocrinol Metab."},{"key":"B22","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1530\/EJE-10-0475","article-title":"Thyroid- associated ophthalmopathy; quality of life follow-up of patients randomized to treatment with antithyroid drugs or radioiodine","volume":"163","author":"Abraham-Nordling","year":"2010","journal-title":"Eur J Endocrinol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1016\/j.ophtha.2006.02.060","article-title":"Evaluation of the national eye institute visual function questionnaire in Graves' ophthalmopathy","volume":"113","author":"Bradley","year":"2006","journal-title":"Ophthalmology."},{"key":"B24","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/S0895-4356(99)00069-4","article-title":"Test-Retest Reliability of the GO-QOL: a disease-specif quality of life questionnaire for patients with Graves' ophthalmopathy","volume":"52","author":"Terwee","year":"1999","journal-title":"J Clin Epidemiol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.jcjo.2013.12.007","article-title":"Evaluation of thyroid eye disease: quality- of-life questionnaire (TED-QOL) in Korean patients","volume":"49","author":"Son","year":"2014","journal-title":"Can J Ophtalmol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.1136\/bjophthalmol-2011-300487","article-title":"Validity and reability of the TED-QOL: a new three item questionnaire to assess quality of life in thyroid eye disease","volume":"12","author":"Fayers","year":"2011","journal-title":"Br J Ophtalmol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1016\/j.jfma.2013.12.002","article-title":"Assessing quality of life in Taiwanese patients with Graves' ophthalmopathy","volume":"114","author":"Lin","year":"2015","journal-title":"J Formosan Med Assoc."},{"key":"B28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/09286586.2016.1255974","article-title":"Measurement properties of Persian translated version of Graves orbitophaty quality of life questionnaire: validation study","volume":"21","author":"Kashkouli","year":"2016","journal-title":"Ophthalmic Epidemiol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1038\/eye.2011.359","article-title":"Assessing Graves' ophthalmopathy-specific quality of life in Korean patients","volume":"26","author":"Choi","year":"2012","journal-title":"Eye."},{"key":"B30","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/j.ajo.2011.02.018","article-title":"Quality of life in German Graves orbitophathy population","volume":"152","author":"Ponto","year":"2011","journal-title":"Am J Ophthalmol."}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fendo.2019.00192\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,4]],"date-time":"2019-04-04T04:36:57Z","timestamp":1554352617000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fendo.2019.00192\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,4]]},"references-count":30,"alternative-id":["10.3389\/fendo.2019.00192"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2019.00192","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4,4]]},"article-number":"192"}}